ABBV


Abbvie (ABBV): A Top Winning Stock to Buy

By Amber Hestla This past weekend, I had a chance to talk to a friend who’s been trading financial markets for more than …

AbbVie Inc (ABBV) Has More Than Just a Terrible Setback for Rova-T to Confront; Bear Warns Further Downside Risk Lies Ahead

Alex Arfaei notes he continues to be the “lone bear” on this biotech player- especially after lead pipeline asset Rova-T is no longer looking at quick approval.

Who’s Better Pharma Dividend Stock: Gilead Sciences, Inc. (GILD) or AbbVie Inc (ABBV)?

by Bob Ciura Pharmaceutical companies are among the strongest dividend growth stocks in the market. For example, Gilead Sciences, Inc.

Analysts Bullish On These Two Healthcare Giants: Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV)

Analysts are weighing in today on healthcare giants Gilead Sciences, Inc. (NASDAQ:GILD) and AbbVie Inc (NYSE:ABBV).

AbbVie Inc (ABBV) Announces 3Q:16 Financial Results; Shares Fall 4%

AbbVie Inc (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2016. “We delivered another strong quarter, with EPS growth ahead …

Company Update (NYSE:ABBV): AbbVie Inc Reports Second-Quarter 2016 Financial Results

AbbVie Inc (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2016. “AbbVie continues to deliver on our long-term strategy, as demonstrated …

AbbVie Inc (ABBV): A Favorable Risk/Reward Investment Opportunity

By Dirk S. Leach Today, long term investors are challenged in navigating the course and lining up that long drive for a investment …

Stock Update (NYSE:ABBV): AbbVie Inc to Highlight its Innovative Pipeline to the Investment Community

At an R&D Day meeting today for the investment community, AbbVie Inc (NYSE:ABBV), a global biopharmaceutical company, will present an overview of its innovative …

Company Update (NYSE:ABBV): AbbVie Inc Reports First-Quarter 2016 Financial Results

AbbVie Inc (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2016. “AbbVie delivered strong first-quarter results, including significant revenue and EPS …

Company Update (NYSE:ABBV): AbbVie Inc Reports Full-Year 2015 and Fourth-Quarter Financial Results

AbbVie Inc (NYSE:ABBV) announced financial results for the fourth quarter and full year ended Dec. 31, 2015.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts